Greg Slabodkin

#AndelynBiosciences manufactures custom #genetherapy for rare genetic disorder with its #AAV Curator platform. The #CDMO made the therapy in 10 months, just 14 months after a child was diagnosed with #NEDAMSS, a rare and degenerative #neurologicaldisorder. https://t.co/ntveQXZKUN

#PiramalPharma will expand two U.S. sites with a $90 million investment to boost capacity for sterile injectables and payload-linkers for #bioconjugate drugs, adding to a prior $570 million U.S. investment. https://t.co/3HZh6EW7nc #pharmamanufacturing #AntibodyDrugConjugates #ADC

#Bayer says #tariff threat is manageable and will not adjust global #manufacturing footprint. CEO Bill Anderson said the company has "considerable" production capabilities in the U.S. and Europe but has no plans to shift it. https://t.co/5kwkdBCAR1 #pharmamanufacturing #tariffs

#Roche invests over $280 million to build #biopharma site in Shanghai. The facility is meant to localize production of #Vabysmo and strengthen end-to-end supply capabilities in #China. https://t.co/kvOx3uY8td #pharmamanufacturing #antibodies #retinaldiseases #biopharmaceuticals

#Roche's #Genentech will build a $700 million #manufacturing facility in North Carolina. The 700,000-square-foot plant in Holly Springs will support Roche and Genentech's future portfolio of next-generation #obesity medicines. https://t.co/p7bTph3qAC #pharmamanufacturing

#EliLilly expands #PurdueUniversity alliance with $250 million investment to accelerate #pharmaceutical innovation. The Lilly-Purdue 360 Initiative will target #drug development, #AI, #manufacturing, and #workforcetraining. https://t.co/2jy1Mfd2Fx #robotics #pharmamanufacturing

#Lonza reported strong Q1 performance across its #CDMO business and continued recovery in its Capsules & Health Ingredients division. The company confirmed its full-year guidance and highlighted robust commercial demand. https://t.co/61AeaM6tAC #contractmanufacturing #biologics

#Takeda will invest $30 billion in its U.S. operations over the next five years. CEO Christophe Weber said the investment strategy is not new and is meant to upgrade Takeda's "massive" #manufacturing network. https://t.co/sGgsHUYkWs #pharmamanufacturing #tariffs #pharmaceuticals

#RatioTherapeutics to build #radiopharma #manufacturing site in Utah to vertically integrate its pipeline of #radiopharmaceuticals for #cancer treatment and monitoring with capabilities for end-to-end production. https://t.co/VhVQ4DbGpb #pharmamanufacturing #cancertreatment

#GileadSciences plans to invest $11 billion in U.S. R&D and #manufacturing, including building three new facilities and upgrading three existing sites. The amount is in addition to a previously planned spend of $21 billion. https://t.co/uxk15UNMwm #pharmamanufacturing #pharma

#AGCBiologics enters into partnership with South Korea-based #NoveltyNobility to support development of a first-in-class #bispecificantibody drug. The collaboration involves #CellLineDevelopment using AGC's CHEF1 expression system. https://t.co/CVaEUNyTau #immunology #oncology

#AptarCSPTechnologies launched a #cGMP-compliant #manufacturing facility in New Jersey. The site, a collaboration with #MOD3Pharma, will support clinical #packaging for #oralsoliddose and capsule-based DPI drugs. https://t.co/S8cNVCEqkO #pharmamanufacturing #materialscience

#XelliaPharmaceuticals announced plans to phase out operations at its Copenhagen #manufacturing site over next eight to 10 years. The Danish drugmaker said the move is part of broader strategic shift aimed at long-term sustainability. https://t.co/zqqo2ZirRm #pharmamanufacturing

#BristolMyersSquibb to invest $40 billion in U.S. R&D and #manufacturing. The announcement follows President #Trump signing an #executiveorder aimed at expediting approval process for domestic #pharmaceutical manufacturing facilities. https://t.co/64RufYk0TU #pharmamanufacturing

#Axplora boosts #AntibodyDrugConjugate and #GLP1 #manufacturing capabilities amid demand for complex active pharmaceutical ingredients. Expansions at two sites France have solidified the #CDMO's position in targeting the hot markets. https://t.co/tLj7PYe575 #contractmanufacturing

#SKpharmteco has opened a #cGMP #plasmid suite to support #cellandgenetherapy #manufacturing. The expansion at its King of Prussia, Pennsylvania facility adds critical capacity for high-quality plasmid production at a key U.S. #biomanufacturing site. https://t.co/d0zo62ylfm #CDMO

#PCIPharmaServices completes #AjinomotoAlthea buy as part of $1 billion investment strategy. The acquisition strengthens PCI's position in sterile drug #manufacturing and advanced #drugdelivery systems. https://t.co/Ds6IMu5dxQ #contractmanufacturing #fillfinish #CDMO #CDMOs